Geron Corp. (GERN)
1.38
+0.10
(+7.81%)
USD |
NASDAQ |
Dec 11, 16:00
1.37
-0.01
(-0.72%)
After-Hours: 18:30
Geron Free Cash Flow: -132.68M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cassava Sciences, Inc. | -83.91M |
| SELLAS Life Sciences Group, Inc. | -30.62M |
| GT Biopharma, Inc. | -11.36M |
| Ultragenyx Pharmaceutical, Inc. | -466.39M |
| Arcellx, Inc. | -201.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.58M |
| Cash from Investing (Quarterly) | 13.35M |
| Cash from Financing (Quarterly) | 0.542M |
| Free Cash Flow Per Share (Quarterly) | -0.0202 |
| Free Cash Flow to Equity (Quarterly) | -14.92M |
| Free Cash Flow to Firm (Quarterly) | -4.843M |
| Free Cash Flow Yield | -14.44% |